TriSalus Life Sciences (TLSI) Other Non-Current Liabilities (2020 - 2026)

TriSalus Life Sciences' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 71.01% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 71.01% decrease from a year earlier, with the FY2025 full-year figure at $10.1 million, up 21.98% from the prior year.
• Other Non-Current Liabilities declined to $2.7 million in Q1 2026 per TLSI's latest filing, from $10.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $18.6 million in Q4 2023 and bottomed at $369000.0 in Q4 2022.
• The 5-year median for Other Non-Current Liabilities is $5.4 million (2023), against an average of $6.2 million.
• Across the five-year window, Other Non-Current Liabilities tumbled 94.65% in 2022 and soared 4949.32% in 2023, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $369000.0 in 2022, then surged by 4949.32% to $18.6 million in 2023, then plunged by 55.37% to $8.3 million in 2024, then increased by 21.98% to $10.1 million in 2025, then sank by 72.97% to $2.7 million in 2026.
• Per Business Quant, the three latest TLSI Other Non-Current Liabilities figures stand at $2.7 million (Q1 2026), $10.1 million (Q4 2025), and $5.0 million (Q3 2025).